AbbVie Inc (ABBV)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$262.24
Buy
$262.46
$2.37 (+0.91%)
Prices updated at 02 Oct 2026, 19:41 EDT
| Prices minimum 15 mins delay
Prices in USD
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
| $262.42 - $257.87 | |
| $269.39 - $190.75 | |
| 2.66 | |
| 459,326.80m | |
| 73.43 | |
| - | |
| 2,766,517 | |
| - | |
| 6,348,699.15 | |
| 0.02 | |
| 1,838.68m | |
| US00287Y1091 | |
| 2.37 | |
| - |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.